I don’t buy your attempt at discrediting CYDY or Nader
I don’t buy your attempt at discrediting CYDY or Nader personally. Nader wouldn’t say in the last conference call that they needed one last item and they could file the EUA in the Philippines if it wasn’t possible.
That means to me... that Nader believes that he needs no prior USA EUA before he can apply for an EUA through their Philippines agent Chiral Pharmaceutical. That one item I believe is the the early ratio of death in the CD-12 trial.
Meaning that they don’t need to know or care to know all the end points as long as they get to see the life saving mortality that Vyrologix can provide in the trial a little earlier so they could attain a deal before Vyrologix is EUA approved and sold for a premium price somewhere else in the world.
The Philippines changed their whole process to do this. Just because you didn’t read it properly or your questions wasn’t answered in the way you approve. It doesn’t mean that this possibility isn’t the way it is.
I have to say one more thing that did bother me in that conference call on the same subject. Nader said something that isn’t what I would expect from a CEO that is looking to sell in a first come first serves basis. I respected what he said and why he said it. When he said. I would rather save the doses for the USA then anywhere else because this country has done so much for him and he wants to pay it back as a 40 year plus immigrant to our fine country. This is not a direct quote. In not so many words but paraphrased in my words.
For me as a share holder I don’t want any prejudice to any buyer and believe as a business you sell to the first buyer. So it caught my attention when he said what he said.
1
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...
Continue Reading
Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....
Continue Reading
Big Leagues Beckon: Everpure Enters the S&P 500 Another day, another dollar, but today ain't just any day for Everpure. They’re stepping up from the minor leagues and grabbing their spot in the illustrious S&P 500 lineup. We're talking about a milestone that every company dreams of, but few achieve—this ain't your regular Tuesday headline. Stock Market's Stamp of...
Continue Reading
High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...
Continue Reading
Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...
Continue Reading
The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...
Continue Reading
What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...
Continue Reading
Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...
Continue Reading
A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...
Continue Reading
Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...
Continue Reading
Top 5 Most Recently Viewed Articles
Equinor ASA's Share Buy-Back Program Update Equinor ASA (OSE: EQNR, NYSE: EQNR) has recently provided insights regarding its share buy-back activities, specifically focusing on the ongoing fourth tranche of its 2024 share buy-back program. This initiative reflects Equinor's continued commitment to enhancing shareholder value through strategic transactions in the market....
Continue Reading
Ryder System, Inc. Reports Mixed Third Quarter Earnings Ryder System, Inc. (NYSE:R) recently announced its earnings for the third quarter, revealing mixed results. The earnings per share (EPS) for the quarter stood at $3.57, slightly exceeding analysts' expectations of $3.55 and showing a 3.8% increase from the previous year's $3.44 per share. Quarterly Revenue Insights...
Continue Reading
Broadcom's Journey to the $1 Trillion Club The phenomenal success of the U.S. economy has spawned companies that not only achieve billion-dollar valuations but also transform entire industries. A key player in this narrative is Broadcom (NASDAQ: AVGO), which is a bedrock of the technology sector, especially with its recent stock performance and strategic shift toward...
Continue Reading
Introducing FintechVendors.com: A Game Changer in Financial Services FintechVendors.com (FVC) has emerged as a revolutionary platform offering a free, comprehensive directory featuring over 4,400 fintech providers. This innovative service aims to transform how financial services professionals discover vendors, streamlining the vendor selection process and conserving...
Continue Reading
Kleinfelder's Strategic Leadership Changes The Kleinfelder Group, Inc., an established name in engineering and professional services, has announced significant leadership promotions aimed at enhancing its growth trajectory. Victor Auvinen has taken on the role of Executive Vice President and Chief Revenue Officer (CRO), while Chris King has been elevated to Executive Vice...
Continue Reading